In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 593 for your search:
Cancer Type/Condition:  Liver cancer, adult primary
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-001, NCT00554905

3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: RFA-002, NCT00555334

4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-003, NCT00556803

5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: rfa-004, NCT00557024

6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SYSUCC-HCC004, NCT00768157

7.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SUMS-5010, Cholangiocarcinoma, Surgery, Drainage, NCT00797121

8.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: nsc96-2314-B-075-037-MY3, IRB-96-04-01, NCT00567216

9.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LCI-001, NCT01102335

10.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCH-2010-04, NCT01125865

11.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: V99C1-026, IRB:98-09-09, NCT01298284

12.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: HCC0011, NCT01350206

13.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: HCC0012, NCT01351194

14.

Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 2011PTAHCC, NCT01409499

15.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: HCC-0013, NCT01415063

16.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 12 to 70
Sponsor: Other
Protocol IDs: 23-16/11/2001, NCT01438437

17.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 170/11, NCT01552291

18.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 65 to 85
Sponsor: Other
Protocol IDs: HCC17, NCT01570075

19.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: HCC16, NCT01570166

20.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PRIGA, 2011-005909-79, NCT01575574

21.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CIH-XWG-201205001, NCT01758679

22.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: DGD-44-057, NCT01806740

23.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 15 to 85
Sponsor: Other
Protocol IDs: Fo-Lap, NCT01819961

24.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TACE-Sorafenib, NCT01833299

25.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-213, NCT01849588
1     
New Search